Lamictal XR Gains Indication for Conversion to Monotherapy for Partial Seizures - MPR
Links shared publicly online about this topic.
- 337total visits
View full resource at empr.com
Most Recently Shared on April 26, 2011 at 2:49 pm By:
oncologynurseadvisor.com — “GlaxoSmithKline announced that the FDA has approved Lamictal XR (lamotrigine extended-release tablets) for conversion to monotherapy in patients 13 years with partial seizures taking one anti-epileptic drug.” View full resource at oncologynurseadvisor.com
Most Recently Shared on April 26, 2011 at 2:45 pm By: